Schedule 13G ownership disclosure

Amicus Therapeutics Inc

Security class unavailable · CUSIP: 03152W109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,853,467
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-20-000044
Form type
SC 13G/A
Filer
AMICUS THERAPEUTICS, INC.
CIK
CIK 1178879
Filed
Feb 06, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub